Aaron I. Davis, Director, 10% Owner at Odonate Therapeutics, Inc. (ODT), sold 1,200,000 shares at $2.23 ($2.5M) on 2021-11-17, disclosed to the SEC on 2021-11-19.
Open-market sale of $2.5M ODT by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.17 | 600,000 | $1.3M | 52.0% |
| 2 | $2.23 | 170,000 | $379K | 15.2% |
| 3 | $1.95 | 250,000 | $488K | 19.5% |
| 4 | $1.84 | 150,000 | $276K | 11.0% |
| 5 | $1.92 | 30,000 | $58K | 2.3% |
| Total | $2.09 avg | 1,200,000 |
| $2.5M |
| 100% |
| Filing → |
| TYRA | SELL | 2023-02-13 | $4.4M | — | Filing → |
| RAIN | BUY | 2022-11-08 | $11.3M | — | Filing → |
| ITOS | SELL | 2022-05-11 | $20.2M | — | Filing → |